AU7377196A - Steroid receptor binding compositions and steroid-sparing preparations thereof in immunosuppression and inflammation - Google Patents
Steroid receptor binding compositions and steroid-sparing preparations thereof in immunosuppression and inflammationInfo
- Publication number
- AU7377196A AU7377196A AU73771/96A AU7377196A AU7377196A AU 7377196 A AU7377196 A AU 7377196A AU 73771/96 A AU73771/96 A AU 73771/96A AU 7377196 A AU7377196 A AU 7377196A AU 7377196 A AU7377196 A AU 7377196A
- Authority
- AU
- Australia
- Prior art keywords
- inflammation
- steroid
- glucocorticoid
- concomitant
- extracts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/723—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Food Science & Technology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1996/015550 WO1998013057A1 (fr) | 1996-09-27 | 1996-09-27 | Compositions de liaison aux recepteurs steroidiens et preparations associees limitant les effets steroidiens, pour traiter immunosuppressions et inflammations |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7377196A true AU7377196A (en) | 1998-04-17 |
Family
ID=22255873
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU73771/96A Abandoned AU7377196A (en) | 1996-09-27 | 1996-09-27 | Steroid receptor binding compositions and steroid-sparing preparations thereof in immunosuppression and inflammation |
Country Status (7)
Country | Link |
---|---|
EP (2) | EP1007066B1 (fr) |
AT (1) | ATE309813T1 (fr) |
AU (1) | AU7377196A (fr) |
CA (2) | CA2268099C (fr) |
DE (1) | DE69635462T2 (fr) |
ES (1) | ES2252760T3 (fr) |
WO (1) | WO1998013057A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1185281A1 (fr) * | 1999-06-02 | 2002-03-13 | Oxford Natural Products PLC | Combinaison de glucosamine avec des extraits d'herbes de tripterygium, ligustrum et erycibe |
GB0001703D0 (en) * | 2000-01-25 | 2000-03-15 | Glaxo Group Ltd | Assay |
FR2952072B1 (fr) * | 2009-11-05 | 2013-09-27 | Pf Medicament | Procede de production de triptolide |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4005108A (en) * | 1973-04-03 | 1977-01-25 | Research Corporation | Novel anti-leukemic diterpenoid triepoxides |
US4241536A (en) * | 1976-11-10 | 1980-12-30 | Saint Firmin Annette R | Embryogenesis in vitro, induction of qualitative and quantitative changes in metabolites produced by plants and products thereof |
US4328309A (en) * | 1980-07-02 | 1982-05-04 | The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services | Method for producing tripdiolide, triptolide and celastrol |
WO1991013627A1 (fr) * | 1990-03-14 | 1991-09-19 | The Board Of Regents, The University Of Texas System | Extraits de tripterygium wilfordii hook f et composants de ces derniers utiles pour l'immunosuppression |
CN1095278A (zh) * | 1993-05-14 | 1994-11-23 | 安庆市余良卿制药厂 | 雷公藤贴膏 |
AU2646295A (en) * | 1994-05-18 | 1995-12-05 | Ligand Pharmaceuticals, Inc. | Screening for cytokine modulators |
WO1996008262A1 (fr) * | 1994-09-15 | 1996-03-21 | Pharmagenesis, Inc. | Composition et procede d'immunotherapie |
-
1996
- 1996-09-27 EP EP96936024A patent/EP1007066B1/fr not_active Expired - Lifetime
- 1996-09-27 AT AT96936024T patent/ATE309813T1/de not_active IP Right Cessation
- 1996-09-27 CA CA002268099A patent/CA2268099C/fr not_active Expired - Fee Related
- 1996-09-27 EP EP05024950A patent/EP1645281A1/fr not_active Withdrawn
- 1996-09-27 AU AU73771/96A patent/AU7377196A/en not_active Abandoned
- 1996-09-27 DE DE69635462T patent/DE69635462T2/de not_active Expired - Lifetime
- 1996-09-27 WO PCT/US1996/015550 patent/WO1998013057A1/fr active IP Right Grant
- 1996-09-27 ES ES96936024T patent/ES2252760T3/es not_active Expired - Lifetime
- 1996-09-27 CA CA002658989A patent/CA2658989A1/fr not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1645281A1 (fr) | 2006-04-12 |
ATE309813T1 (de) | 2005-12-15 |
CA2268099C (fr) | 2008-12-16 |
DE69635462T2 (de) | 2006-08-17 |
DE69635462D1 (de) | 2005-12-22 |
EP1007066A1 (fr) | 2000-06-14 |
ES2252760T3 (es) | 2006-05-16 |
EP1007066A4 (fr) | 2002-10-23 |
CA2268099A1 (fr) | 1998-04-02 |
WO1998013057A1 (fr) | 1998-04-02 |
EP1007066B1 (fr) | 2005-11-16 |
CA2658989A1 (fr) | 1998-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1092433A3 (fr) | Compositions et méthodes pour traiter ou prevenir les maladies inflammatoires | |
HK1027802A1 (en) | Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors | |
MX9606546A (es) | Compuestos inhibidores de la enzima conversiva de interleukina-1 beta. | |
BG110703A (en) | PHARMACEUTICAL COMPOSITION, INCLUDING HUMAN ANTIBODIES CONNECTING HUMAN TNF ALPHA AND HIS APPLICATION | |
UA66745C2 (en) | INTERLEUKIN-1b-CONVERTING ENZYME INHIBITORS, PHARMACEUTICAL COMPOSITION AND A METHOD FOR TREATMENT OF DISEASES | |
AU2275397A (en) | Troponin subunits and fragments useful as angiogenesis inhibitors | |
CA2281844A1 (fr) | Nouveaux steroides anti-oestrogenes, compositions pharmaceutiques associees et leur mode d'utilisation | |
WO1997022619A3 (fr) | INHIBITEURS DE L'ENZYME CONVERTISSANT L'INTERLEUKINE-1$g(b) | |
WO1999062510A3 (fr) | Compositions renfermant des agents anti-microtubules pour le traitement ou la prevention de maladies inflammatoires | |
WO2002047706A3 (fr) | Inhibition sélective de la cox-2 au moyen d'extraits végétaux | |
WO2002047708A3 (fr) | Inhibition selective de cox-2 a partir d'extraits de plantes comestibles | |
WO1998024804A3 (fr) | INHIBITEUR DE L'ENZYME DE CONVERSION DE L'INTERLEUKINE 1$g(b) | |
WO1999058555A3 (fr) | Promedicaments de propofol solubles dans l'eau | |
WO1998051662A3 (fr) | Composes et methodes d'inhibition de l'expression de vcam-1 | |
WO2004046345A3 (fr) | Utilisation de fragments hmgb en tant qu'agents anti-inflammatoires | |
IL137509A0 (en) | Glucocorticoid-selective anti-inflammatory agents | |
UA72909C2 (en) | Cinnamide derivatives useful in the treatment of inflammatory and immune diseases, a composition containing such derivatives and a method for the preparation of cinnamide derivatives | |
AU1711197A (en) | Method for treating sexual dysfunctions | |
EP1032556A4 (fr) | Composes pharmaceutiquement actifs et procedes d'utilisation | |
WO2001094951A3 (fr) | Inhibiteurs d'inflammation induite par la proteine c reactive | |
AU7377196A (en) | Steroid receptor binding compositions and steroid-sparing preparations thereof in immunosuppression and inflammation | |
MX9701776A (es) | Uso de factores de crecimiento similares a insulina i y ii para la inhibicion de la respuesta inflamatoria. | |
WO2000012045A3 (fr) | Procede de traitement de troubles neuro-degeneratifs | |
WO2000071140A3 (fr) | Procedes et compositions de modulation de la reponse immunitaire et de traitement des maladies inflammatoires | |
WO1999014234A3 (fr) | Stimulation ou inhibition de l'angiogenese et de la cardiovascularisation |